Literature DB >> 16731465

Pacemaker implantation and quality of life in the Mode Selection Trial (MOST).

Kirsten E Fleischmann1, E John Orav, Gervasio A Lamas, Carol M Mangione, Eleanor Schron, Kerry L Lee, Lee Goldman.   

Abstract

BACKGROUND: Dual-chamber pacemakers restore AV synchrony compared with ventricular pacemakers, but the effects on health-related quality of life (QOL) are uncertain.
OBJECTIVES: The purpose of this study was to assess the effect of pacemaker implantation, clinical factors, and pacing mode on QOL.
METHODS: The Mode Selection Trial (MOST) randomized 2,010 patients with sinus node dysfunction to rate-modulated right ventricular (VVIR) or dual-chamber (DDDR) pacing. A longitudinal analysis of serial QOL measures (Short Form-36 [SF-36], Specific Activity Scale, and time trade-off utility) was performed. In patients who crossed over from VVIR to DDDR because of severe pacemaker syndrome, the last known QOL prior to crossover was carried forward.
RESULTS: Pacemaker implantation resulted in substantial improvement in almost all QOL measures. Subjects 75 years or older experienced significantly less improvement in functional status and physical component summary scores than did younger subjects. In longitudinal analyses of the effect of pacing mode on QOL, significant improvement in three SF-36 subscales was observed with DDDR pacing compared with VVIR pacing: role physical [62.8 points (95% confidence interval [CI] 60.2, 65.5) vs 56.4 (95% CI 53.7, 59.1)], role emotional [85.0 (95% CI 82.9, 87.0) vs 81.9 (95% CI 79.9, 84.0)], and vitality [51.8 (95% CI 50.3, 53.3) vs 49.3 (95% CI 47.8, 50.7)], but not in other SF-36 subscales, the Specific Activity Scale, or utilities. The gains in QOL were larger than the declines associated with 1 year of aging but smaller than those associated with heart failure.
CONCLUSION: Pacemaker implantation improved health-related QOL. The mode selected was associated with much smaller, but significant, improvements in several domains, particularly role physical function.

Entities:  

Mesh:

Year:  2006        PMID: 16731465     DOI: 10.1016/j.hrthm.2006.02.1031

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

Review 1.  Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.

Authors:  Shaojie Chen; Zhenglong Wang; Marcio Galindo Kiuchi; Bruno Rustum Andrea; Mitchell W Krucoff; Shaowen Liu; Helmut Pürerfellner
Journal:  Clin Res Cardiol       Date:  2016-02-25       Impact factor: 5.460

Review 2.  Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population.

Authors:  Christine Capone; Jill P Buyon; Deborah M Friedman; William H Frishman
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

3.  Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome.

Authors:  Yasutsugu Nagamoto; Tomohito Inage; Teruhisa Yoshida; Tomohiro Takeuchi; Takeki Gondo; Yujiro Fukuda; Eiichi Takii; Kenta Murotani; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2011-04-20       Impact factor: 2.037

4.  "Why Would I Choose Death?": A Qualitative Study of Patient Understanding of the Role and Limitations of Cardiac Devices.

Authors:  Rachel A Hadler; Nathan E Goldstein; David B Bekelman; Barbara Riegel; Larry A Allen; Robert M Arnold; Matthew E Harinstein; Dio Kavalieratos
Journal:  J Cardiovasc Nurs       Date:  2019 May/Jun       Impact factor: 2.083

Review 5.  The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment.

Authors:  Monica Parry; Harriette G C Van Spall; Kerri-Anne Mullen; Sharon L Mulvagh; Christine Pacheco; Tracey J F Colella; Marie-Annick Clavel; Shahin Jaffer; Heather J A Foulds; Jasmine Grewal; Marsha Hardy; Jennifer A D Price; Anna L E Levinsson; Christine A Gonsalves; Colleen M Norris
Journal:  CJC Open       Date:  2022-04-19

Review 6.  Cardiac implantable electrical devices in women.

Authors:  Kalaimani Elango; Anne B Curtis
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

7.  Is conventional cardiac pacing harmful in patients with normal ventricular function?

Authors:  Luiz Antonio Batista de Sá; Salvador Rassi; Márcia Andery Ludovico Batista
Journal:  Arq Bras Cardiol       Date:  2013-10-22       Impact factor: 2.000

8.  Impact of a poor functional capacity on the clinical outcomes in patients with a pacemaker implantation -Results from the Japanese Heart Rhythm Society Registry.

Authors:  Takanori Arimoto; Eiichi Watanabe; Ritsuko Kohno; Kenji Shimeno; Kan Kikuchi; Atsushi Doi; Kanki Inoue; Takashi Nitta; Akihiko Nogami; Haruhiko Abe; Ken Okumura
Journal:  J Arrhythm       Date:  2020-12-09

Review 9.  The Impact of Cardiac Devices on Patients' Quality of Life-A Systematic Review and Meta-Analysis.

Authors:  Kevin Willy; Christian Ellermann; Florian Reinke; Benjamin Rath; Julian Wolfes; Lars Eckardt; Florian Doldi; Felix K Wegner; Julia Köbe; Nexhmedin Morina
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-10

10.  Effects of cardiac resynchronization therapy on health-related quality of life in older adults with heart failure.

Authors:  Karin F Hoth; Justin Nash; Athena Poppas; Kristin E Ellison; Robert H Paul; Ronald A Cohen
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.